Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-054939
Filing Date
2010-03-12
Accepted
2010-03-12 12:16:31
Documents
14
Period of Report
2010-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1082178
2 AMENDED & RESTATED SECURED CONVERTIBLE NOTE dex411.htm EX-4.11 27619
3 OMNIBUS AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT dex10291.htm EX-10.29.1 7581
4 AMENDED & RESTATED PROMISSORY NOTE dex1037.htm EX-10.37 34632
5 OMNIBUS AMENDMENT TO LOAN AGREEMENT dex10381.htm EX-10.38.1 7283
6 SECOND AMENDMENT TO MORTGAGE AGREEMENT dex10401.htm EX-10.40.1 16185
7 SERVICES AGREEMENT dex1042.htm EX-10.42 66749
8 ATRYN GENERATION I CLINICAL & COMMERCIAL SERVICE AGREEMENT dex1043.htm EX-10.43 276165
9 LIST OF SUBSIDIARIES dex21.htm EX-21 1536
10 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 2074
11 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 10293
12 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 10272
13 CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 6103
14 GRAPHIC g90471g43c46.jpg GRAPHIC 1331
  Complete submission text file 0001193125-10-054939.txt   1552054
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0101
Type: 10-K | Act: 34 | File No.: 000-21794 | Film No.: 10676576
SIC: 2836 Biological Products, (No Diagnostic Substances)